Related Experiment Video

Updated: Jun 17, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Protacs for treatment of cancer

Kathleen M Sakamoto1

  • 1Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA. kms@ucla.edu

Pediatric Research
|January 16, 2010
PubMed

Insights

Cancer cells produce unwanted proteins, but new Protac molecules can target these proteins for destruction. This novel technology exploits the cell's natural protein degradation pathway to treat cancer.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Protein degradation is essential for cellular health, primarily mediated by the ubiquitin-proteasome system.
  • Defects in ubiquitination are linked to diseases like cancer, neurodegenerative disorders, and metabolic conditions.
  • The ubiquitin-proteasome system tags unwanted proteins with ubiquitin for degradation by the 26S proteasome.

Purpose of the Study:

  • To explore the potential of manipulating protein synthesis and degradation for cancer treatment.
  • To introduce Proteolysis Targeting Chimeric molecules (Protacs) as a novel therapeutic strategy.

Main Methods:

  • Designing Protacs as heterobifunctional nanomolecules.
  • Utilizing Protacs to recruit cancer-causing proteins to the ubiquitin-proteasome machinery.

Main Results:

  • Protacs are approximately 10 nm in size.
  • Protacs effectively recruit target proteins for degradation via the ubiquitin-proteasome pathway.

Conclusions:

  • Protac technology offers a novel approach to cancer therapy by hijacking cellular degradation pathways.
  • Further development of Protacs holds promise for treating various cancers.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Related Concept Videos

Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...